NuVasive reported a net loss of $18.3 million in the first quarter of 2014, down from the same period last year when the company earned a net income of $851,000.
NuVasive also reported a gross profit of $134.2 million in Q1, up from $120.4 million it reported in Q1 2013. The company's Q1 revenue is $177.5 million, up from $159.5 million during the same period last year.
"Results in the first quarter of 2014 were solidly in line with our expectations, and place us on track to achieve full year guidance by continuing to execute our share-taking strategy," said Alex Lukianov, chairman and CEO in a press release. "While staying true to NuVasive's core philosophy of driving innovation to improve spine patient outcomes, we are evolving our organization to maintain a start-up mentality and to continue to lead spine innovation as a much larger, and increasingly profitable, global organization."
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws